GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WntResearch AB (XSAT:WNT) » Definitions » Float Percentage Of Total Shares Outstanding

WntResearch AB (XSAT:WNT) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 04, 2024)


View and export this data going back to 2010. Start your Free Trial

What is WntResearch AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, WntResearch AB's float shares is 0.00 Mil. WntResearch AB's total shares outstanding is 8.66 Mil. WntResearch AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, WntResearch AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, WntResearch AB's Institutional Ownership is 0.00%.


WntResearch AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

WntResearch AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/8.66
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WntResearch AB (XSAT:WNT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WntResearch AB (XSAT:WNT) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
Address
Per Albin Hansson, Road 41, Medeon Science Park, Malmo, SWE, 205 12
WntResearch AB is a cancer research company. The company develops anti-metastatic therapies based on the mechanisms underlying the metastatic process.

WntResearch AB (XSAT:WNT) Headlines

No Headlines